Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...
15h
Zacks.com on MSNCRISPR Therapeutics Stock Before Q4 Earnings: To Buy or Not to Buy?CRISPR Therapeutics CRSP is expected to report fourth-quarter and full-year 2024 earnings later this month. The Zacks ...
16h
AZoLifeSciences on MSNNew CRISPR Tool Reveals Key Lymphoma GenesThis study presents an optimized CRISPR-Cas12a system for large-scale genetic screening, revealing critical genes involved in lymphoma development and therapy.
Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results